11 urban drug centralized procurement offers the results of the election
Drug prices dropped on average by 52%
Beijing, Dec. 8, reporter Wu Jiajia said: The National Bureau of Medical Insurance said on 8th place that the national organization of the centralized drug pilot project has progressed smoothly and the results of the "4 + 7" Pilot Generic Drug have 25 centralized plans for public procurement. Compared to the minimum purchase price of the same drug in the pilot city in 2017, the average price of the proposed price decreased by 52%, with the largest drop being 96%.
It is understandable that the centralized procurement of this drug round is based on centralized public procurement contracts forming the public procurement base based on central public procurement in Beijing, Tianjin, Shanghai, Chongqing and Shenyang, Dalian, Xiamen, Guangzhou, Shenzhen, Chengdu. The Joint Public Procurement Office collects scattered drug purchases in 11 pilot cities to form the effect of large-scale purchases. The contract notice indicates the size of the purchase of each variety and the pharmaceutical producers are obviously expected to benefit from the contract. The Independent Quotation Declaration removes the "gold sale" phenomenon, it is useful to change the price in quantity, significantly reduce the cost of drugs and effectively reduce the burden of drug charges on patients, it is beneficial to reduce the costs of interregional marketing of enterprises. At the same time, this centralized pilot project on public procurement allows for fair competition between generic medicines and original medicines for research by assessing consistency that contributes to strengthening competition and promoting generic substitution.
The person in charge of the joint acquisition service indicated that the pharmaceutical companies attach great importance to this centralized procurement and all the undertakings involved take part in the declaration reflecting the enthusiasm of the enterprises involved in the national organization of the pilot project on centralized drug procurement . In the end, there were 25 centralized generics for 31 pilot generics, with 81% success. Among them, 22 generic medicines passed the 88% grade and 3 original 12% drugs and the generic substitution effect. Compared to the minimum purchase price of the same drug in the pilot city in 2017, the average price of the proposed price decreased by 52%, with the largest drop being 96%. After the end of the publicity period, the company will determine and publish the results of the election. The pilot office will lead and promote pilot programs and support the policies of the pilot cities, implement the results of the bids and realize the benefits of the masses.
Why is there a strong drop in the price of the drug to be chosen? Will a sharp fall in prices have a negative impact on pharmaceutical manufacturers? The person in charge of the Joint Acquisition Service indicated that the overall drop in drug prices selected for centralized drug delivery in the country is in line with expectations, demonstrating the strength of alliance supplies and supply of quantities. Masses can get high-quality and low-priced medicines, and manufacturing companies can also save on transaction costs and focus on R & D to understand quality. "The high cost of drugs is an important medical problem in China, according to the study of the authoritative department, in the sale price of drugs, the production price and the reasonable profit of the manufacturing company represent only a small part, so the price of the pre- After a drastic decline, the main reason for pushing is "moisture", such as sales costs, and drug manufacturers can still make money. "The answer is that participation in a" center " Hezir procurement 4 + 7 "and quotes a purchase based on enterprise. The production and operational situation is determined by itself. It is understandable that the companies that will be selected want to reduce the price by price.
The person in charge of the Joint Procurement Service also said the price of the chosen drug dropped sharply. For pharmaceutical companies, the current non-economic and long-term benefits are good. First, the volume of purchases significantly reduced the cost of drug entry into the hospital. Second, the promise of timely payouts reduces corporate and finance costs. Third, alliance orders significantly reduce their market costs. Fourthly, in order to change the market price, the unit cost of the drug is reduced by the scale effect. These factors can hedge the impact of drug price cuts and give tangible benefits to selected companies. The massive public procurement model promoted by the national centralized drug delivery organization releases pharmaceutical manufacturers from the "gold sale" competition, which is conducive to redirecting their efforts to improve the quality of drugs and promote of proper monitoring of drug research and development. It is of great importance for the healthy development of the Chinese pharmaceutical industry.
In addition, the Chief Cabinet Officer said that choosing a drug in the hospital and using priority is the key to the success of the national organization of pilots for centralized drug appointment. The next step is to include drug use in the management of medical insurance contracts and to clarify the responsibility for breach of the contract and the way to deal with them. The second is to implement a payment policy. In order to clarify drug medical insurance with the same common name and different commodity names, working rules and transitional policies paid under the same payment standard and direct the insured person to rational use of drugs. The third is to strengthen the monitoring and control of the procurement of selected and unselected drugs and to find measures to resolve the unusual situation in a timely manner. Fourthly, hospitals that reduce the costs of medical insurance funds due to the use of selected varieties in the standard. When the total amount of the medical insurance budget is not reduced, the balance is reserved for the hospital in proportion to the promotion of the reform of the wage distribution system in the hospital and mobilizing the enthusiasm of the medical staff. The fifth is to establish and improve the system of assessment of medical insurance and assessment of medical institutions and to include the use of selected medicines in the system of assessment of health insurance and index evaluation and to create appropriate systems of remuneration and punishment.